amphetamine has been researched along with acamprosate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cioli, I; Duprè, S; Nencini, P; Pascucci, T; Pisetzky, F; Spirito, A | 1 |
Gibula-Bruzda, E; Koltunowska, D; Kotlinska, JH | 1 |
1 review(s) available for amphetamine and acamprosate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for amphetamine and acamprosate
Article | Year |
---|---|
Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats.
Topics: Acamprosate; Alcohol Deterrents; Amphetamine; Animals; Central Nervous System Stimulants; Discrimination Learning; Dizocilpine Maleate; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Reaction Time; Taurine | 1999 |
The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Topics: Acamprosate; Amphetamine; Animals; Anxiety; Bridged Bicyclo Compounds; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Ligands; Male; Memantine; Pyridines; Rats; Receptors, Ionotropic Glutamate; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Taurine; Thiazoles | 2013 |